China Chromium-Capsule Scandal Focus Turns To Provincial Regulators
This article was originally published in PharmAsia News
Executive Summary
China’s scandal involving contaminated drug capsules is leading to concerns of laxity by regulatory authorities as well as law enforcement officials who may have been partly responsible.
China’s scandal involving contaminated drug capsules is leading to concerns of laxity by regulatory authorities as well as law enforcement officials who may have been partly responsible. The Supreme People’s Procuratorate sent investigators to the region where the chromium-tainted capsules were produced to join local authorities in their probe. The SPP interest is in whether government employees allowed the contamination, according to sources. The SPP issued a circular in the area asking for reports of illegal dereliction of duty involving the incident, which has led to confiscation of 77 million capsules, detention of 54 people, nine criminal arrests and the closing of eight capsule makers in three provinces. (Click here for more
)
“China Investigates Possible Dereliction Of Duty In Medicine-Capsule Scandal” – Xinhua (China) (4/25/12)